Meeting in the middle.
Support for copycat versions of biotechnology drugs is growing quickly in the US Congress. Meredith Wadman reports.
D001709:Biotechnology / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends; D016527:Drug Costs / Q000331:legislation & jurisprudence* / Q000639:trends; D004345:Drug Industry / Q000191:economics* / Q000331:legislation & jurisprudence; D016568:Drugs, Generic / Q000191:economics* / Q000600:supply & distribution; D006801:Humans
D016568:Drugs, Generic